Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corporate Profile for Possis Medical, dated Febuary 4, 2000.


Business Editors

--(BUSINESS WIRE)

The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services.

Published Date:   February 4, 2000

Company Name:     Possis Medical, Inc.

Address:          9055 Evergreen Boulevard NW
                  Minneapolis, MN 55433-8003

Main Telephone
 Number:          612-780-4555

Internet Home
 Page Address
  (URL)           www.possis.com

Chief Executive
 Officer:         Robert G. Dutcher

Chief Financial
 Officer:         Russel E. Carlson

Investor Relations
 Contact:         Eapen Chacko
 Business number: 612-717-1157
 E-mail address:

Public Relations
 Contact:         Eapen Chacko
 Business number: 612-717-1157
 E-mail address:

Industry:         Medical Devices

Trading Symbol/
 Exchange:        POSS/NMS-NASDAQ

Market Makers:    Gerard Klauer Mattison, First Union Securities, John
                  G. Kinnard, George K. Baum


Company description: The mission of Possis Medical, Inc. is to provide healthcare professionals with innovative, high quality medical devices that will enhance and expand medical treatment options to cost-effectively restore health and improve the quality of life for patients worldwide.

The primary product line is the AngioJet(R) Rheolytic(TM) Thrombectomy thrombectomy /throm·bec·to·my/ (throm-bek´tah-me) surgical removal of a clot from a blood vessel.

throm·bec·to·my
n.
Excision of a thrombus.
 System, which provides definitive, rapid and safe removal of blood clots Blood Clots Definition

A blood clot is a thickened mass in the blood formed by tiny substances called platelets. Clots form to stop bleeding, such as at the site of cut.
 (thrombus thrombus /throm·bus/ (throm´bus) pl. throm´bi   a stationary blood clot along the wall of a blood vessel, frequently causing vascular obstruction. ) from native coronary arteries Coronary arteries
The two main arteries that provide blood to the heart. The coronary arteries surround the heart like a crown, coming out of the aorta, arching down over the top of the heart, and dividing into two branches.
, saphenous vein saphenous vein
n.
Either of two main superficial veins of the leg, one larger than the other, that begin at the foot.


Saphenous vein
A long vein in the thigh or calf commonly used for bypass grafts.
 grafts, and arteriovenous arteriovenous /ar·te·rio·ve·nous/ (-ve´nus) both arterial and venous; pertaining to or affecting an artery and a vein.

ar·te·ri·o·ve·nous
adj.
Abbr.
 access grafts. The company is currently the only FDC-approved mechanical thrombectomy device for use in the heart.

The AngioJet System is a platform technology, which the Company intends to use for other indications, such as peripheral vascular disease Peripheral Vascular Disease Definition

Peripheral vascular disease is a narrowing of blood vessels that restricts blood flow. It mostly occurs in the legs, but is sometimes seen in the arms.
 and ischemic stroke. The AngioJet System is protected by a series of five issued patents in the United States. Possis Medical, Inc. will soon commence the TIME I clinical trial, at six of the nation's leading stroke centers, to test a highly miniaturized AngioJet System catheter for treating ischemic stroke. Ischemic stroke affects over 600,000 patients per year and costs the economy over $40 billion annually in treatment costs and lost productivity.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Feb 4, 2000
Words:310
Previous Article:Wolverine World Wide, Inc. Closes 1999 With Record Fourth Quarter and Annual Earnings.
Next Article:NetStaff Announces Rapid Growth in Clients -- Staffing Industry's First Business-to-business Web Portal Gaining Quick Acceptance; New Chief Financial...
Topics:



Related Articles
Possis Medical, Inc. Receives FDA Clearance for Marketing New Xpeedior Catheter In AV Access Indication; Kidney Dialysis Patients Have Powerful New...
Possis Medical, Inc. Announces Management Change.
Possis Medical, Inc. Commences TIME 1 Clinical Trial for Ischemic Stroke.
Possis Medical, Inc. Announces Workforce Reduction.
Possis Medical, Inc. Launches New Catheter at American College of Cardiology Conference.
Possis Medical, Inc. Announces Profitability for Third Quarter.
Mary K. Brainerd Named To Possis Medical Board of Directors.
CLIPPERS VS. PORTLAND.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles